1Paul-Samojedny M,Owczarek A,Kowalczyk M,et al.Association of interleukin 2(IL-2),interleukin 6(IL-6),and TNF-alpha gene polymorphisms with paranoid schizophrenia in a Polish population[J].J Neuropsychiatry Clin Neurosci,2013,25(1):72-82. 被引量：1
2Singh B,Bera NK,Nayak CR,et al.Immunomodulation in schizophrenia:A study among the Indian schizophrenia patients of Siliguri,West Bengal[J].Asian J Psychiatr,2011,4(4):277-283. 被引量：1
3Miller BJ,Buckley P,Seabolt W,et al.Meta-analysis of cytokine alterations in schizophrenia:clinical status and antipsychotic effects[J].Biol Psychiatry,2011,70(7):663-671. 被引量：1
4Turncliff R,Hard M,Du YC,et al.Relative bioavailability and safety of aripiprazole lauroxil,a novel once-monthly,long-acting injectable atypical antipsychotic,following deltoid and gluteal administra-tion in adult subjects with schizophrenia[J].Schizophr Res,2014,159(2):404-410. 被引量：1
5Zhu EF,Gai SA,Opel CF,et al.Synergistic Innate and Adaptive Immune Response to Combination Immunotherapy with AntiTumor Antigen Antibodies and Extended Serum Half-Life IL-2[J].Cancer Cell,2015,27(4):489-501. 被引量：1
3Bantis C,Heering P,Aker S,et al.Influence of Cytokine Cene Polymorphisms on IgA Nephrepathy[J].Renal Faiture,2008,30(2):135-140. 被引量：1
4Stangou M,Alexopoulos E,Papagianni A,et al.Urinary levels of epidermal growth factor,interleukin-6 and monocyte chemoattractant protein-1may act as predictor markers of renal function outcome in inmmunoglobulin Anephropathy[J].Original Article,2009,14(6):613-620. 被引量：1
5Hatada K,Akai Y,Kummatani N,et al.Prognostic value of urinary interleukin 6 in patients with IgA nephropnthy:An 8-Year foHow-up study[J].Nephron,2002,92(4):824-826. 被引量：1
6Watts RA,Scott DG.Epidemiology of the vasculities[J].Current Opinion in Rheumntol,2003,15(1):11-16. 被引量：1
7Himhnta S,Miyamoto T.Elevated levels of interhukin-6 in cerebrospinal fluid from patientswith systemic lupus erytlIematosus and central nervous system involement[J].Arthritis Rheum,1990,33(5):644-649. 被引量：1
8Cash H,Relle M,Menke J,et al.Interleukin 6(IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice:The IL-6 pathway as a new therapeutie target in treatment of antoimmune kidney disease in systemic lupus erythematosus[J].The Journal of Rheumatology,2010,37(1):60-70. 被引量：1
9Panichi V,Migliori M,De Pietro S,et al.Creactive pro-tein as a marker of chronic infl am mation in uremia patients[J].Blood Purif,2000,18(3):183-190. 被引量：1
10Garibotto G,Sofia A,Procepio V,et al.Perpheral tissue release of interleukin-6 in patients with chronic kidney diseasea:effects of end-stage renal disease and mierionflamratory state[J].International Society ofNephrology,2006,70(2):384-390. 被引量：1
